Posted in

VITAMIN D – Lec# 3, P # 1023 Ch: # 80

VITAMIN D - Lec# 3, P # 1023 Ch: # 80
  • Vitamin D strongly increases calcium absorption from the intestine.
  • It also has important effects on bone deposition and bone resorption.(breaking down old bone and releasing its minerals, especially calcium and phosphate, into the blood.)
  • Vitamin D itself is not the final active form.
  • It must first be converted through reactions in the liver and kidneys into the active hormone 1,25-dihydroxycholecalciferol, also called:
    • 1,25(OH)₂D₃
    • Calcitriol
  • The sequence of vitamin D activation is shown in Fig. 80.9.

Cholecalciferol (Vitamin D3) Is Formed in the Skin

  • Several sterol-derived compounds belong to the vitamin D family and have similar functions.
  • The most important form is vitamin D₃ (cholecalciferol).
  • Vitamin D₃ is formed in the skin when ultraviolet rays from sunlight act on 7-dehydrocholesterol.
  • Therefore: 7-dehydrocholesterol + ultraviolet light → cholecalciferol (vitamin D₃)
  • Appropriate exposure to sunlight therefore helps prevent vitamin D deficiency.
  • Vitamin D obtained from food is functionally similar to the cholecalciferol produced in the skin.

KEY CONCEPT

  • Vitamin D → increases intestinal calcium absorption.
  • Vitamin D must be activated in the: Liver → kidneys → calcitriol [1,25(OH)₂D₃]
  • Skin + sunlight → vitamin D₃ (cholecalciferol).
  • Calcitriol = active form of vitamin D.

Conceptual Examples

  • Sunlight:
    UV rays act on 7-dehydrocholesterol in skin → vitamin D₃ forms.
  • Activation:
    Vitamin D₃ → liver → kidneys → calcitriol.
  • Main effect:
    Active vitamin D → intestine → ↑ calcium absorption.

Figure 80.9 — Activation of Vitamin D and Control of Calcium

Easiest Concept

Think of vitamin D₃ as an inactive raw material that must pass through 2 organs to become active:

Skin → Liver → Kidney → Active vitamin D → Intestine → ↑ Blood Ca²⁺

Follow the figure from top to bottom

  • Skin
    • Produces cholecalciferol (vitamin D₃).
    • This form is not yet fully active.
  • Liver
    • Converts vitamin D₃ → 25-hydroxycholecalciferol.
    • This is the main circulating/storage form of vitamin D.
    • Increased 25-hydroxycholecalciferol feeds back and inhibits further formation in the liver.
  • Kidney
    • Converts 25-hydroxycholecalciferol → 1,25-dihydroxycholecalciferol (calcitriol).
    • Calcitriol = active vitamin D.
    • PTH stimulates this kidney activation.

What does active vitamin D do?

Calcitriol acts on the intestinal epithelium and increases:

  • Calcium-binding protein → helps carry Ca²⁺ through intestinal cells.
  • Calcium-stimulated ATPase → helps pump Ca²⁺ into blood.
  • Alkaline phosphatase → assists the calcium-absorbing process.

Result:

↑ Intestinal calcium absorption → ↑ plasma Ca²⁺ concentration

PTH feedback

When blood Ca²⁺ is low:

↓ Ca²⁺ → ↑ PTH → kidney makes more calcitriol → intestine absorbs more Ca²⁺ → blood Ca²⁺ rises

When blood Ca²⁺ rises sufficiently:

↑ Ca²⁺ → inhibits PTH

This prevents calcium from rising too much.

Dashed arrows

  • 25-hydroxyvitamin D → liver inhibition = negative feedback.
  • ↑ Plasma Ca²⁺ → PTH inhibition = negative feedback.

🔑 KEY CONCEPT

Vitamin D₃ → Liver makes 25-OH D → Kidney makes active 1,25-(OH)₂D → Intestine absorbs more Ca²⁺

And:

Low Ca²⁺ → ↑ PTH → ↑ active vitamin D → ↑ Ca²⁺ absorption

One-line memory

“Skin makes it, liver stores it, kidney activates it, intestine uses it to absorb calcium.”

Cholecalciferol Is Converted to 25-Hydroxycholecalciferol in the Liver

  • The first activation step of cholecalciferol (vitamin D₃) occurs in the liver.
  • In the liver: Vitamin D₃ → 25-hydroxycholecalciferol
  • 25-hydroxycholecalciferol inhibits its own further formation by negative feedback.
  • This feedback is important for two main reasons:
    • It keeps plasma 25-hydroxycholecalciferol nearly constant, even when vitamin D₃ intake increases greatly (Fig. 80.10).
    • It prevents rapid conversion of all stored vitamin D₃, helping preserve vitamin D stores in the liver.
  • Once vitamin D₃ is converted to 25-hydroxycholecalciferol, it remains in the body for only a few weeks.
  • In contrast, vitamin D₃ itself can remain stored in the liver for many months.

Formation of 1,25-Dihydroxycholecalciferol in the Kidneys and Its Control By Parathyroid Hormone

  • In the proximal tubules of the kidneys, 25-hydroxycholecalciferol is converted to 1,25-dihydroxycholecalciferol (calcitriol) (Fig. 80.9). 25-hydroxycholecalciferol → kidney → 1,25-dihydroxycholecalciferol
  • 1,25-dihydroxycholecalciferol is the most active form of vitamin D.
  • Earlier vitamin D forms have less than 1/1000 of its activity.
  • Therefore, without functioning kidneys, vitamin D loses almost all of its effectiveness.
  • This kidney conversion requires parathyroid hormone (PTH).
  • Without PTH, almost no 1,25-dihydroxycholecalciferol is produced.
  • Therefore, PTH strongly controls the functional activity of vitamin D in the body.

KEY CONCEPT

  • Vitamin D activation occurs mainly in two steps: Vitamin D₃ → Liver → 25-hydroxycholecalciferol → Kidney + PTH → 1,25-dihydroxycholecalciferol (calcitriol)
  • Liver step → controlled by feedback.
  • Kidney step → requires PTH.
  • Calcitriol = most active vitamin D form.
  • Liver storage protects vitamin D supply for months.

Conceptual Examples

  • High vitamin D intake:
    ↑ Vitamin D₃ → feedback limits liver conversion → 25-hydroxycholecalciferol stays near normal.
  • Role of kidney:
    25-hydroxycholecalciferol → kidney → active calcitriol.
  • Role of PTH:
    ↓ PTH → very little calcitriol formation → vitamin D effects decrease greatly.
  • Easy sequence:
    Skin/diet → vitamin D₃ → liver → 25-OH D → kidney + PTH → calcitriol.

Vitamin D₃ Intake vs Plasma 25-Hydroxycholecalciferol

This graph shows one simple idea:

Once vitamin D intake is adequate, increasing vitamin D₃ intake further causes very little increase in plasma 25-hydroxycholecalciferol.

X-axis

Intake of vitamin D₃ (× normal)

  • 1.0 = normal intake
  • 2.0 = twice normal intake
  • 2.5 = 2.5 times normal intake

Y-axis

Plasma 25-hydroxycholecalciferol (× normal)

This is the main circulating storage form of vitamin D produced in the liver.

  • 1.0 = normal plasma level
  • Below 1.0 = reduced level
  • Around 1.0 = maintained near normal

🔴 Red curve

At very low vitamin D intake

The curve is very steep.

So:

Vitamin D₃ intake ↓↓↓ → plasma 25-hydroxycholecalciferol ↓↓↓

This means severe vitamin D deficiency occurs mainly when intake becomes very low.

As vitamin D intake increases

The red curve rises rapidly toward:

≈ 1.0 × normal

So even a relatively modest increase from very low intake quickly restores plasma 25-hydroxycholecalciferol toward normal.

After reaching the plateau

The red line becomes almost flat.

From roughly normal intake up to 2.5 times normal intake:

Vitamin D₃ intake ↑↑

but

Plasma 25-hydroxycholecalciferol changes very little.

This flat part is the key feature of the graph.

Why does the curve flatten?

The liver converts:

Vitamin D₃ → 25-hydroxycholecalciferol

But this conversion is feedback regulated.

When enough 25-hydroxycholecalciferol has formed:

25-hydroxycholecalciferol ↑

→ inhibits further conversion of vitamin D₃

→ plasma level stays relatively stable.

So the body prevents a large rise in 25-hydroxycholecalciferol even when vitamin D intake increases.

“Normal range” bracket

The bracket over the flat portion means:

Over a fairly wide range of vitamin D₃ intake, plasma 25-hydroxycholecalciferol remains close to normal.

So the body has a buffering/protective mechanism.

Easy analogy 🪣

Think of the liver as a factory.

At very low vitamin D supply:

Raw material ↓ → product ↓

But once enough vitamin D is available:

Factory has enough product → factory slows further production

So giving more raw material does not greatly increase the final product.

Whole graph in one flow

Very low vitamin D₃ intake

Very little 25-hydroxycholecalciferol formed

Plasma level falls

But:

Adequate vitamin D₃ intake

25-hydroxycholecalciferol reaches near-normal level

Feedback inhibition limits further conversion

Curve becomes flat

Plasma 25-hydroxycholecalciferol remains nearly constant

⭐ Key Concept

Vitamin D deficiency appears mainly at very low vitamin D intake. Once intake is adequate, increasing vitamin D₃ even several-fold produces little additional rise in plasma 25-hydroxycholecalciferol because its formation in the liver is feedback regulated.

Calcium Ion Concentration Controls the Formation of 1,25-Dihydroxycholecalciferol

  • Plasma calcium concentration controls calcitriol formation inversely (Fig. 80.11).
  • This means: ↓ Ca²⁺ → ↑ 1,25-dihydroxycholecalciferol
    ↑ Ca²⁺ → ↓ 1,25-dihydroxycholecalciferol
  • There are two main reasons:
    • High Ca²⁺ slightly decreases conversion of 25-hydroxycholecalciferol → 1,25-dihydroxycholecalciferol.
    • More importantly, high Ca²⁺ strongly suppresses PTH secretion.
  • When plasma calcium is below about 9–10 mg/100 mL:
    • PTH secretion increases.
    • PTH stimulates the kidneys to convert:
    25-hydroxycholecalciferol → 1,25-dihydroxycholecalciferol
  • When plasma calcium rises above this level:
    • PTH decreases.
    • Less active 1,25-dihydroxycholecalciferol is formed.
    • Instead, 25-hydroxycholecalciferol is converted mainly into 24,25-dihydroxycholecalciferol.
    • This compound has almost no vitamin D activity.
  • When blood calcium is already high, reduced calcitriol formation decreases calcium absorption from:
    • Intestines
    • Bones
    • Renal tubules
  • Therefore, plasma Ca²⁺ falls back toward its normal level.

KEY CONCEPT

  • Low Ca²⁺ → ↑ PTH → ↑ calcitriol → ↑ calcium absorption.
  • High Ca²⁺ → ↓ PTH → ↓ calcitriol → ↓ calcium absorption.
  • This provides an important negative-feedback mechanism for maintaining normal blood calcium.

Conceptual Examples

  • Low blood calcium:
    ↓ Ca²⁺ → ↑ PTH → kidney makes more calcitriol → more calcium becomes available to the blood.
  • High blood calcium:
    ↑ Ca²⁺ → ↓ PTH → ↓ calcitriol → less calcium is absorbed → blood calcium falls toward normal.
  • Easy sequence:
    ↓ Ca²⁺ → ↑ PTH → ↑ calcitriol
    ↑ Ca²⁺ → ↓ PTH → ↓ calcitriol.

Plasma Calcium vs Active Vitamin D

This graph shows a powerful calcium-saving feedback system:

When blood calcium falls even slightly below normal, the body greatly increases active vitamin D (1,25-dihydroxycholecalciferol) to help bring calcium back toward normal.

1️⃣ Understand the axes

X-axis = Plasma calcium (mg/100 mL)
Moving right means blood calcium increases.

Y-axis = Plasma 1,25-dihydroxycholecalciferol (× normal)
This is calcitriol—the active form of vitamin D.

  • 1 = normal level
  • 2 = twice normal
  • 6 = six times normal

2️⃣ ⭐ The “Normal” point

The red star is around:

Plasma calcium ≈ 9–10 mg/100 mL

and

Active vitamin D ≈ 1 × normal

So under normal conditions:

Normal Ca²⁺ → normal active vitamin D

3️⃣ 🔴 Red curve — each part explained

Right side: Calcium is normal or high

When plasma calcium is approximately 10 mg/100 mL or higher, the red curve stays very low.

Why?

Because the body already has enough calcium.

Therefore:

Ca²⁺ adequate/high

PTH secretion suppressed

→ less kidney conversion to active vitamin D

1,25-dihydroxycholecalciferol ↓

This prevents unnecessary additional calcium absorption.

4️⃣ The steep vertical part is VERY important

Around 9–10 mg/100 mL, the curve changes dramatically.

A small fall in plasma calcium below normal causes a huge increase in active vitamin D.

So:

Ca²⁺ slightly ↓

⬇️

PTH ↑↑

⬇️

Kidneys increase conversion:

25-hydroxycholecalciferol → 1,25-dihydroxycholecalciferol

⬇️

Active vitamin D ↑↑

This is why the red curve rises so steeply.

5️⃣ Left upper plateau

When calcium remains below normal, active vitamin D can become approximately:

5–6 × normal

The curve then plateaus.

The important concept is:

Low calcium strongly stimulates formation of active vitamin D, but the response has a maximum.

6️⃣ Why does LOW calcium increase active vitamin D?

There are two mechanisms, with PTH being the most important.

Main mechanism ⭐

Plasma Ca²⁺ ↓

Parathyroid glands detect low Ca²⁺

PTH ↑

→ PTH stimulates renal 1α-hydroxylase

→ conversion of 25-hydroxycholecalciferol → 1,25-dihydroxycholecalciferol ↑

Additional effect

Higher calcium itself also tends to reduce conversion toward 1,25-dihydroxycholecalciferol.

So both mechanisms help explain the inverse relationship.

7️⃣ What does increased active vitamin D actually achieve?

The body isn’t increasing active vitamin D just for the sake of it.

Its major purpose here is:

Increase intestinal calcium absorption

So:

Blood Ca²⁺ ↓

PTH ↑

Active vitamin D ↑↑

Intestinal Ca²⁺ absorption ↑↑

More calcium enters blood

Plasma Ca²⁺ moves back toward normal

This is negative feedback.

8️⃣ Why is the curve so steep near normal calcium?

This is the beautiful physiological point.

Calcium concentration must be kept within a very narrow range because Ca²⁺ is essential for:

  • nerve function
  • muscle contraction
  • cardiac function
  • intracellular signaling

Therefore, even a small decrease below normal triggers a large compensatory response.

Small Ca²⁺ ↓ → Big active vitamin D ↑

🧠 Easiest analogy: Calcium thermostat 🌡️

Think of plasma calcium like room temperature.

When temperature is normal:

Heater stays low.

If temperature falls:

Heater switches on strongly.

Similarly:

Normal/high Ca²⁺

→ little need for active vitamin D

But:

Ca²⁺ falls below normal

→ PTH turns up the vitamin-D system

→ intestinal calcium absorption increases

→ calcium is restored.

🎯 Entire graph in one flow

Plasma Ca²⁺ ↓ slightly below normal

PTH ↑

Kidney 1α-hydroxylase ↑

25-OH vitamin D → 1,25-(OH)₂ vitamin D ↑↑

Intestinal Ca²⁺ absorption ↑↑

Plasma Ca²⁺ restored toward normal Key Concept — Figure 80.11

Plasma calcium and active vitamin D have an inverse relationship near the normal calcium level: a slight decrease in plasma calcium causes a large increase in 1,25-dihydroxycholecalciferol, mainly through increased PTH. The increased active vitamin D then greatly increases intestinal calcium absorption and helps restore plasma calcium.

🔑 One-line memory trick

“Calcium falls → PTH rises → active vitamin D rises → gut absorbs more calcium.”

ACTIONS OF VITAMIN D

  • The active form of vitamin D, 1,25-dihydroxycholecalciferol (calcitriol), acts mainly on the:
    • Intestines
    • Kidneys
    • Bones
  • Its overall effect is to increase the movement of calcium and phosphate into the extracellular fluid and help regulate their concentrations.
  • Vitamin D receptors are present in many body cells and are located mainly in the cell nucleus.
  • The vitamin D receptor has:
    • A hormone-binding domain
    • A DNA-binding domain
  • After binding vitamin D, the receptor combines with the retinoid-X receptor.
  • This complex binds to DNA and usually increases gene transcription, although in some cases it decreases transcription.
  • The vitamin D receptor has about 1000 times greater affinity for 1,25-dihydroxycholecalciferol than for 25-hydroxycholecalciferol.
  • Therefore, 1,25-dihydroxycholecalciferol is much more biologically active.

“Hormonal” Effect of Vitamin D to Promote Intestinal Calcium Absorption

  • 1,25-Dihydroxycholecalciferol acts like a hormone to increase intestinal calcium absorption.
  • Over about 2 days, it increases formation of calbindin, a calcium-binding protein in intestinal epithelial cells.
  • Calbindin helps transport calcium from the intestinal lumen into the cell cytoplasm.
  • Calcium then crosses the basolateral membrane by facilitated diffusion.
  • The amount of calcium absorbed is directly related to the amount of calbindin present.
  • Calbindin remains in intestinal cells for several weeks, even after 1,25-dihydroxycholecalciferol is removed.
  • Therefore, vitamin D produces a prolonged increase in calcium absorption.
  • Calcitriol may also increase:
    • Calcium-stimulated ATPase in the brush border.
    • Alkaline phosphatase in intestinal epithelial cells.
  • The exact importance of these additional effects is still unclear.

KEY CONCEPT

  • Calcitriol = active vitamin D.
  • It acts through a nuclear receptor → DNA → altered gene transcription.
  • Its receptor has about 1000× greater affinity for calcitriol than for 25-hydroxycholecalciferol.
  • Main intestinal action: Calcitriol → ↑ calbindin → ↑ intestinal Ca²⁺ absorption
  • Calbindin remains for weeks, so the calcium-absorbing effect is long lasting.

Conceptual Examples

  • Vitamin D action:
    Calcitriol enters target cell → binds nuclear receptor → receptor complex binds DNA → changes protein production.
  • Calcium absorption:
    ↑ Calcitriol → ↑ calbindin → more Ca²⁺ enters intestinal cells and then the blood.
  • Prolonged effect:
    Calcitriol disappears → calbindin remains for weeks → calcium absorption stays increased for some time.

Vitamin D Promotes Phosphate Absorption By the Intestines

  • Phosphate is normally absorbed easily from the intestine.
  • Vitamin D further increases intestinal phosphate absorption.
  • The active form, 1,25-dihydroxycholecalciferol (calcitriol), increases activity of the sodium-phosphate co-transporter on the luminal membrane of small-intestinal epithelial cells.
  • This transporter works similarly to sodium-phosphate co-transporters in the renal tubules.
  • This effect is especially important when phosphate availability is low.

Vitamin D Decreases Renal Calcium and Phosphate Excretion

  • Vitamin D slightly increases calcium and phosphate reabsorption in the renal tubules.
  • Therefore, less calcium and phosphate are lost in the urine.
  • However, this renal effect is relatively weak and is not a major regulator of their extracellular concentrations.

Effect of Vitamin D on Bone and Its Relation to Parathyroid Hormone Activity

  • Vitamin D has important effects on both bone resorption and bone deposition.
  • Excess vitamin D can increase bone resorption.
  • Vitamin D is also important for the bone-resorbing action of PTH.
  • Without vitamin D, PTH-induced bone resorption is greatly reduced or may be prevented.
  • This effect may involve increased calcium transport across cell membranes.
  • In smaller amounts, vitamin D promotes bone calcification and mineralization.
  • One important mechanism is: Vitamin D → ↑ intestinal Ca²⁺ + phosphate absorption → ↑ minerals available for bone
  • Vitamin D can also increase bone mineralization even without increasing intestinal absorption.
  • This effect may also involve movement of Ca²⁺ across osteoblast or osteocyte cell membranes.

KEY CONCEPT

  • Vitamin D → ↑ intestinal phosphate absorption.
  • Vitamin D → slight ↑ renal Ca²⁺ and phosphate reabsorption → ↓ urinary loss.
  • High vitamin D → can promote bone resorption.
  • Vitamin D is required for much of PTH-induced bone resorption.
  • Smaller amounts of vitamin D → promote bone calcification and mineralization.

Conceptual Examples

  • Low phosphate availability:
    ↑ Calcitriol → ↑ sodium-phosphate co-transport → more phosphate absorbed from intestine.
  • Kidney:
    Vitamin D → ↑ Ca²⁺ and phosphate reabsorption → slightly less lost in urine.
  • Bone resorption:
    PTH + adequate vitamin D → greater bone resorption.
  • Bone mineralization:
    Vitamin D → ↑ calcium + phosphate availability → better bone calcification.

Bibliography Duda GN, Geissler S, Checa S, Tsitsilonis S, Petersen A, Schmidt-Bleek K.
The decisive early phase of bone regeneration. Nat Rev Rheumatol.
2023;19:78–95.
Ensrud KE, Crandall CJ. Osteoporosis. Ann Intern Med. 2024
Jan;177(1):ITC1–ITC16. https://doi.org/10.7326/AITC202401160.
Foessl I, Dimai HP, Obermayer-Pietsch B. Long-term and sequential
treatment for osteoporosis. Nat Rev Endocrinol. 2023;19:520–533.
Gafni RI, Collins MT. Hypoparathyroidism. N Engl J Med. 2019;380:
1738–1747.
Giustina A, Bilezikian JP, Adler RA, Banfi G, et al. Consensus state￾ment on vitamin D status assessment and supplementation: whys,
whens, and hows. Endocr Rev. 2024;45:625–654.
Hannan FM, Kallay E, Chang W, et al. The calcium-sensing receptor in
physiology and in calcitropic and noncalcitropic diseases. Nat Rev
Endocrinol. 2018;15:33–51.

Leave a Reply

Your email address will not be published. Required fields are marked *